Jaci Mcdole News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Since the COVID-19 immunisation started almost a year ago in January 2021, 60.2 per cent of the world population has received at least one dose of a COVID-19 vaccine and only 9.4 per cent of people in low-income countries have received at least one dose (source: our world in data). While there are many challenges to do so, the repeated argument being ‘pharma companies should forego Intellectual Property (IP) to expedite universal immunisation’. Should pharma companies waive IP during the pandemic? Will this ensure universal immunisation and equal distribution of therapies? Let’s find out...

Hospital and provider groups are growing fearful that Congress won’t act to prevent billions in cuts to Medicare payments scheduled to start next year after lawmakers failed to deal with them in a government spending bill that lawmakers cleared yesterday.

A revised proposal to waive international intellectual property protections on Covid-19 vaccines shows good faith from developing countries seeking to ramp up immunization efforts, but it may not be enough to persuade holdout nations to come on board, legal and policy observers say.